Turning complex biological data into clarity, strategy, and innovation.
Biotech and pharma face unprecedented challenges—constrained budgets, data complexity, and the need for faster R&D decisions. G2 Quantix Solutions empowers organizations to cut through the noise, transforming biological and clinical data into actionable insights that accelerate discovery, development, and company growth.
Founded by Gary Ge, Ph.D., a computational drug discovery and data strategy leader with 15+ years of experience, G2 Quantix brings a unique blend of scientific depth and executive perspective. Gary helped build and scale OmicSoft’s flagship products (ArrayServer, OncoLand, DiseaseLand)—platforms now relied upon by 15 of the top 20 global biopharma companies. His leadership at Amgen and Vor Bio spanned the full R&D data lifecycle, from early discovery through regulatory filings, balancing technical rigor with strategic direction.
Our Expertise
We help biotech and pharma teams unlock the value of their data, using approaches that are both cutting-edge and practical.
⚙️ AI/ML for Drug Discovery
We design predictive models grounded in biological reality—from single-cell perturbation to compound and antibody screening. Our lab-in-the-loop AI approach, built on foundation models and active learning, accelerates target discovery while staying data-driven and credible.
🗄️ Research Informatics & Data Platforms
We architect and customize cloud-native ELN, LIMS, and data lakes that are AI-ready by design. With nearly a decade of Bio-IT experience across leading pharma and biotech, we ensure your infrastructure enables—not hinders—innovation.
🧬 Computational Biology & Bioinformatics
From genomics to multi-omics, we build automated, reproducible workflows that free your scientists from repetitive analysis. Our solutions integrate seamlessly into discovery pipelines, empowering your team to focus on novel insights.
✂️ Gene Editing Analytics
We bring proven expertise in gene editing assay design and optimization (Cas9, Cas12a, ABE, CBE). With 5+ years in genotoxicity assessment and FDA interactions, we deliver regulatory-grade data packages for emerging therapies—from multiplexed editing to CAR-T.
🚀 Strategic Biotech Advisory
Having scaled OmicSoft (acquired by QIAGEN) and guided Vor Bio through growth, we support companies at critical inflection points. We advise on CRO partnerships, product strategy, fundraising, and can step in as interim CDO/CTO or Head of Computational Biology.
Why G2 Quantix?
- Strategic + Technical: We don’t just implement tools—we align data, platforms, and science with your business priorities.
- Proven Impact: Our platforms and strategies are used by top-tier pharma and biotech, driving decisions across discovery and development.
- Flexible Engagements: From advisory consulting to interim leadership, we scale to your needs—helping you move forward in uncertain times.